Mauna Kea Technologies SA (EPA:ALMKT)

Market Cap	15.05M
Revenue (ttm)	8.18M +0.3%
Net Income	-10.39M
EPS	-0.14
Shares Out	94.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,029,097
Average Volume	3,052,268
Open	0.1594
Previous Close	0.1586
Day's Range	0.1420 - 0.1594
52-Week Range	0.0609 - 0.1980
Beta	0.82
RSI	73.75
Earnings Date	Apr 9, 2026

About Mauna Kea Technologies

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate reactions as they occur, classify areas of uncertainty, guide surgical interventions, and help diagnose and treat patients. The company was incorporat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 61
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMKT

Financial Performance

In 2024, Mauna Kea Technologies's revenue was 8.42 million, a decrease of -23.69% compared to the previous year's 11.03 million. Losses were -10.40 million, 179.2% more than in 2023.